Efficacy of thalidomide, neurokinin-1 receptor antagonist, and olanzapine in combination with palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and vomiting (CINV) induced by highly emetogenic chemotherapy (HEC): Bayesian network meta-analysis

Journal article

Peer reviewed

Abdullah Alhifany, Ali McBride, Abdulaali Almutairi, Hani M. Babiker, Karen MacDonald and Ivo Abraham

Journal of clinical oncology, Vol.36(15_suppl), pp.e14514-e14514

20/05/2018

Abstract

Abstract only

1 Record Views

Title: Efficacy of thalidomide, neurokinin-1 receptor antagonist, and olanzapine in combination with palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and vomiting (CINV) induced by highly emetogenic chemotherapy (HEC): Bayesian network meta-analysis
Creators - without role: Abdullah Alhifany - University of Arizona
Ali McBride - University of Arizona
Abdulaali Almutairi - University of Arizona
Hani M. Babiker - University of Arizona
Karen MacDonald - Product Innovation and Engineering (United States, Saint James) - LLC
Ivo Abraham - University of Arizona
Publication Details: Journal of clinical oncology, Vol.36(15_suppl), pp.e14514-e14514
Identifiers: 9931439308331
Academic Unit: Umm Al Qura University
Language: English
Resource Type: Journal article